Text and Data Mining valid from 2019-03-25
Received: 23 February 2019
Accepted: 6 March 2019
First Online: 25 March 2019
Compliance with ethical standards
: MB has participated in advisory boards and/or received speaker honoraria from Achaogen, Angelini, Astellas, AstraZeneca, Bayer, Basilea, Biomerieux, Cidara, Gilead, Menarini, MSD, Nabriva, Paratek, Pfizer, Roche, The Medicine Company, Shionogi, Tetraphase, VenatoRx and Vifor. RF reports participation in scientific advisory boards: MSD, Shionogi and lectures: Beckton-Dickinson, MSD, Astelas, Pfizer, Thermo, Estor. SJ reports receiving consulting fees from Drager, Hamilton, Maquet, Medtronic and Fisher & Paykel. CEL reports participations in advisory boards (Bayer Healthcare, Carmat, Faron, ThermoFischer Brahms) and lectures (MSD, Nihon-Koden, Biomérieux). MM has received payment for lectures, advisory board participation and travel expenses from MSD, Jansen, Pfizer, Astelas, Gilead, all outside the submitted work. FP reports lecture fees paid to his institution by ALEXION. JFT reports participation to scientific advisory boards (Astra-Zeneca, Pfizer, MSD, Nabriva, Gilead), lectures (Biomerieux, MSD, Astelas, 3M, Pfizer) and scientific grants (MSD, Pfizer). CV reports personal fees from MSD Int, Gilead, Pfizer, Angelini, Astelas and Basilea. LZ reports scientific grants not related to the review by Jazz Pharmaceuticals.